Search Results - "CARON, Nicholas"
-
1
Therapeutic approaches to Huntington disease: from the bench to the clinic
Published in Nature reviews. Drug discovery (01-10-2018)“…New therapies, including RNA-based and gene therapies, are poised to change the therapeutic landscape for Huntington disease. In this article, Hayden and…”
Get full text
Journal Article -
2
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies
Published in Lancet neurology (01-11-2020)“…Huntington's disease is a fatal neurodegenerative disorder that is caused by CAG-CAA repeat expansion, encoding polyglutamine, in the huntingtin (HTT) gene…”
Get full text
Journal Article -
3
Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells
Published in PloS one (31-08-2012)“…Transglutaminase type 2 (TG2) is a ubiquitously expressed member of the transglutaminase family, capable of mediating a transamidation reaction between a…”
Get full text
Journal Article -
4
Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease
Published in Nucleic acids research (10-01-2020)“…Abstract Huntington disease (HD) is a fatal neurodegenerative disease caused by a pathogenic expansion of a CAG repeat in the huntingtin (HTT) gene. There are…”
Get full text
Journal Article -
5
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease models
Published in Brain (London, England : 1878) (15-10-2024)“…Abstract Huntington’s disease (HD) is a fatal neurodegenerative disease caused by a trinucleotide repeat expansion in exon 1 of the huntingtin gene (HTT) that…”
Get full text
Journal Article -
6
Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
Published in Proceedings of the National Academy of Sciences - PNAS (07-05-2019)“…Whitematter abnormalities are a nearly universal pathological feature of neurodegenerative disorders including Huntington disease (HD). A long-held assumption…”
Get full text
Journal Article -
7
Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice
Published in Neurobiology of disease (01-05-2022)“…Huntington disease (HD) is a neurodegenerative disease caused by a trinucleotide repeat expansion in the HTT gene encoding an elongated polyglutamine tract in…”
Get full text
Journal Article -
8
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease
Published in The Journal of neuroscience (27-01-2021)“…Huntington disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin ( ) gene. Therapeutics that lower HTT…”
Get full text
Journal Article -
9
Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models
Published in BMC biology (01-02-2023)“…The majority of genes in the human genome is present in two copies but the expression levels of both alleles is not equal. Allelic imbalance is an aspect of…”
Get full text
Journal Article -
10
Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity
Published in Neurobiology of disease (01-10-2021)“…Huntington disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HTT gene that codes for an elongated polyglutamine tract in the…”
Get full text
Journal Article -
11
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease
Published in American journal of human genetics (05-12-2019)“…Huntington disease (HD) is a fatal neurodegenerative disorder caused by a gain-of-function mutation in HTT. Suppression of mutant HTT has emerged as a leading…”
Get full text
Journal Article -
12
Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry
Published in Molecular therapy (01-11-2015)“…Huntington disease (HD) is a dominant neurodegenerative disorder caused by a CAG repeat expansion in the Huntingtin gene (HTT). Heterozygous polymorphisms in…”
Get full text
Journal Article -
13
Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
Published in Human molecular genetics (29-09-2020)“…Abstract Huntington disease (HD) is a neurodegenerative disorder that is caused by a CAG repeat expansion in HTT. The length of this repeat, however, only…”
Get full text
Journal Article -
14
Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease
Published in Journal of controlled release (01-03-2024)“…Efficient delivery of therapeutics to the central nervous system (CNS) remains a major challenge for the treatment of neurological diseases. Huntington disease…”
Get full text
Journal Article -
15
Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range
Published in Genetics in medicine (01-12-2020)“…Purpose In some Huntington disease (HD) patients, the “loss of interruption” (LOI) variant eliminates an interrupting codon in the HTT CAG-repeat tract, which…”
Get full text
Journal Article -
16
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
Published in Scientific reports (16-08-2016)“…Increasing evidence supports a role for abnormal immune activation and inflammatory responses in Huntington disease (HD). In this study, we evaluated the…”
Get full text
Journal Article -
17
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
Published in Scientific reports (15-07-2015)“…Quantitation of huntingtin protein in the brain is needed, both as a marker of Huntington disease (HD) progression and for use in clinical gene silencing…”
Get full text
Journal Article -
18
Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks
Published in Journal of controlled release (01-08-2023)“…Lowering mutant huntingtin (mHTT) in the central nervous system (CNS) using antisense oligonucleotides (ASOs) is a promising approach currently being evaluated…”
Get full text
Journal Article -
19
Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions
Published in Human molecular genetics (01-05-2014)“…Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder that can be characterized by the presence of protein inclusions containing…”
Get full text
Journal Article -
20
DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease
Published in Frontiers in cellular neuroscience (05-11-2020)“…Huntington disease (HD) is a devastating neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. Disrupted cortico-striatal…”
Get full text
Journal Article